Overview

A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arthritic Central Retinal Artery Occlusion (CRAO)

Status:
Recruiting
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
Central retinal artery occlusion (CRAO) is an ophthalmologic emergency which leads to severe and permanent vision loss. There is no evidence-based therapy for CRAO. The objective of this GION study is to evaluate the efficacy and safety of KUS121 intravitreal (IVT) injection in participants with acute non-arteritic CRAO.
Phase:
Phase 2
Details
Lead Sponsor:
Kyoto Drug Discovery and Development Co., Ltd.